Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe W Gray

Showing results (181-190 of 261) with videos related to

Pageof 27
Sort By:
Cell Systems|March 19, 2018
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer SubtypesSpencer S Watson, Mark Dane, Koei Chin, et al.
Genome Biology|March 26, 2009
Integrated analysis of breast cancer cell lines reveals unique signaling pathwaysLaura M Heiser, Nicholas J Wang, Carolyn L Talcott, et al.
Annals of Surgical Oncology|May 25, 2012
Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancerRita A Mukhtar, Amy P Moore, Vickram J Tandon, et al.
BMC Cancer|April 20, 2006
Breast tumor copy number aberration phenotypes and genomic instabilityJane Fridlyand, Antoine M Snijders, Bauke Ylstra, et al.
Cell Systems|December 27, 2016
Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein ProfilingSteven M Hill, Nicole K Nesser, Katie Johnson-Camacho, et al.
Nature Medicine|April 16, 2013
A colorectal cancer classification system that associates cellular phenotype and responses to therapyAnguraj Sadanandam, Costas A Lyssiotis, Krisztian Homicsko, et al.
NPJ Systems Biology and Applications|July 21, 2017
Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiersTyler J Moss, Zijun Luo, Elena G Seviour, et al.
Nature Structural & Molecular Biology|November 12, 2013
Rbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridgesMichael T Lovci, Dana Ghanem, Henry Marr, et al.
Breast Cancer Research and Treatment|August 10, 2012
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparibAnneleen Daemen, Denise M Wolf, James E Korkola, et al.
Nature Genetics|June 28, 2008
ESR1 gene amplification in breast cancer: a common phenomenon?Lindsay A Brown, Jeremy Hoog, Suet-Feung Chin, et al.
Pageof 27

Showing results (181-190 of 261) with videos related to

Sort By:
Pageof 27
Cell Systems|March 19, 2018
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer SubtypesSpencer S Watson, Mark Dane, Koei Chin, et al.
Genome Biology|March 26, 2009
Integrated analysis of breast cancer cell lines reveals unique signaling pathwaysLaura M Heiser, Nicholas J Wang, Carolyn L Talcott, et al.
Annals of Surgical Oncology|May 25, 2012
Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancerRita A Mukhtar, Amy P Moore, Vickram J Tandon, et al.
BMC Cancer|April 20, 2006
Breast tumor copy number aberration phenotypes and genomic instabilityJane Fridlyand, Antoine M Snijders, Bauke Ylstra, et al.
Cell Systems|December 27, 2016
Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein ProfilingSteven M Hill, Nicole K Nesser, Katie Johnson-Camacho, et al.
Nature Medicine|April 16, 2013
A colorectal cancer classification system that associates cellular phenotype and responses to therapyAnguraj Sadanandam, Costas A Lyssiotis, Krisztian Homicsko, et al.
NPJ Systems Biology and Applications|July 21, 2017
Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiersTyler J Moss, Zijun Luo, Elena G Seviour, et al.
Nature Structural & Molecular Biology|November 12, 2013
Rbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridgesMichael T Lovci, Dana Ghanem, Henry Marr, et al.
Breast Cancer Research and Treatment|August 10, 2012
Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparibAnneleen Daemen, Denise M Wolf, James E Korkola, et al.
Nature Genetics|June 28, 2008
ESR1 gene amplification in breast cancer: a common phenomenon?Lindsay A Brown, Jeremy Hoog, Suet-Feung Chin, et al.
Pageof 27